A multicentre, randomized, open label, 7-year, controlled trial investigated the efficacy and safety of levonorgestrel or the copper T 380A intrauterine device in parous women

Trial Profile

A multicentre, randomized, open label, 7-year, controlled trial investigated the efficacy and safety of levonorgestrel or the copper T 380A intrauterine device in parous women

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Mar 2016

At a glance

  • Drugs Levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2016 New trial record
    • 23 Feb 2016 Results published in the Contraception.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top